Publications of Tiago Fleming Outeiro
All genres
Journal Article (133)
21.
Journal Article
One-step nanoscale expansion microscopy reveals individual protein shapes. Nature Biotechnology (2024)
22.
Journal Article
32 (10), pp. 3372 - 3401 (2024)
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease. Molecular Therapy 23.
Journal Article
20 (10), pp. 6776 - 6792 (2024)
Cellular prion protein acts as mediator of amyloid beta uptake by caveolin‐1 causing cellular dysfunctions in vitro and in vivo. Alzheimer's & Dementia 24.
Journal Article
364, 143039 (2024)
A versatile yeast model identifies the pesticides cymoxanil and metalaxyl as risk factors for synucleinopathies. Chemosphere 25.
Journal Article
168 (8), pp. 1608 - 1624 (2024)
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry 26.
Journal Article
168 (8), pp. 1514 - 1526 (2024)
Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry 27.
Journal Article
168 (8), pp. 1625 - 1639 (2024)
PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry 28.
Journal Article
14 (5), pp. 917 - 924 (2024)
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms. Journal of Parkinson's Disease 29.
Journal Article
23 (7), p. 669 (2024)
Abandon the NAC in α-synuclein. Lancet Neurology 30.
Journal Article
18, 1412450 (2024)
Age-related alterations in efferent medial olivocochlear-outer hair cell and primary auditory ribbon synapses in CBA/J mice. Frontiers in Cellular Neuroscience 31.
Journal Article
14 (4), pp. 681 - 692 (2024)
Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue. Journal of Parkinson's Disease: JPD 32.
Journal Article
39 (6), pp. 1080 - 1081 (2024)
Reply to: “Rethinking Parkinson's Disease: A Syndromic Perspective”. Movement Disorders 33.
Journal Article
39 (6), pp. 929 - 933 (2024)
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders 34.
Journal Article
49, pp. 1643 - 1654 (2024)
Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson’s Disease. Neurochemical Research 35.
Journal Article
122, 106078 (2024)
Towards a biological diagnosis of PD. Parkinsonism & Related Disorders 36.
Journal Article
23 (5), e14128 (2024)
Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell 37.
Journal Article
39 (4), pp. 321 - 328 (2024)
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene. Neurología (English Edition) 38.
Journal Article
15 (4), 264 (2024)
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death and Disease 39.
Journal Article
31, pp. 3797 - 3804 (2024)
Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose. Cellulose 40.
Journal Article
22, pp. 2670 - 2676 (2024)
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry